Edition:
United States

RXi Pharmaceuticals Reports Qtrly Loss Per Share $0.46


Tuesday, 14 Aug 2018 09:15am EDT 

Aug 14 (Reuters) - Rxi Pharmaceuticals Corp ::RXI PHARMACEUTICALS REPORTS SECOND QUARTER 2018 FINANCIAL RESULTS AND RECENT CORPORATE HIGHLIGHTS.RXI PHARMACEUTICALS CORP - AT JUNE 30, 2018, COMPANY HAD CASH AND CASH EQUIVALENTS OF $5.3 MILLION AS COMPARED WITH $3.6 MILLION AT DECEMBER 31, 2017.RXI PHARMACEUTICALS CORP QTRLY LOSS PER SHARE $0.46.